XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating Expenses [Abstract]        
Research and development $ 20,540 $ 15,964 $ 51,826 $ 40,911
General and administrative 4,240 3,590 12,129 10,177
Total operating expenses 24,780 19,554 63,955 51,088
Operating loss (24,780) (19,554) (63,955) (51,088)
Other income (expense)        
Interest income 1,578 943 5,054 1,202
Other income (expense), net (88) 4 (230) 138
Total other income, net 1,490 947 4,824 1,340
Net loss before income tax (23,290) (18,607) (59,131) (49,748)
Income tax expense (4,420)
Net loss $ (23,290) $ (18,607) $ (59,131) $ (54,168)
Net loss per share, basic $ (0.98) $ (0.79) $ (2.49) $ (4.18)
Net loss per share, diluted $ (0.98) $ (0.79) $ (2.49) $ (4.18)
Weighted-average common shares outstanding, basic 23,790,430 23,562,395 23,788,950 12,954,925
Weighted-average common shares outstanding, diluted 23,790,430 23,562,395 23,788,950 12,954,925